Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

AstraZeneca initiates first-in-human trial of AZD-4635 in advanced solid tumors

July 6, 2016

Preliminary results reported for nivolumab in colon, pancreatic and anal cancer

July 6, 2016

GSK initiates phase I trial of ICOS agonist antibody GSK-3359609

July 5, 2016

FPA-144 named FDA orphan for gastric/gastroesophageal junction cancer

July 5, 2016

Igenica Biotherapeutics presents antineoplastic compounds

July 4, 2016

Targovax initiates phase Ib/II trial of ONCOS-102 in malignant pleural mesothelioma

July 1, 2016

PsiOxus, BMS to evaluate enadenotucirev plus nivolumab

July 1, 2016

OncBioMune highlights promising progress in cancer vaccine development

June 30, 2016

Galena Biopharma discontinues phase III PRESENT trial after interim analysis

June 30, 2016

Merck & Co. and Moderna enter collaboration for novel mRNA-based personalized cancer vaccines

June 30, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...